Philadelphia, PANCT07644585Now EnrollingIRB Ready

Head and Neck Cancer Clinical Trial in Philadelphia, PA

Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.

Sponsored by IBA Proton Therapy, Inc.

Quick Self-Assessment

See if you qualify for this Philadelphia location

Preparing your pre-screening questions…

Expert Care in Philadelphia

Access head and neck cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related head and neck cancer treatment provided free

Apply for This Philadelphia Location

Check if you qualify for this head and neck cancer clinical trial in Philadelphia, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Philadelphia

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Philadelphia site if eligible
  4. 4Begin participation

About This Head and Neck Cancer Study in Philadelphia

This pilot study is designed to evaluate the feasibility of delivering ultra-high dose-rate conformal proton therapy (ConformalFLASH) in participants requiring re-irradiation for head and neck cancer who are not amenable to surgical resection. ConformalFLASH treatment planning and delivery workflows are comparable to those of conventional Stereotactic Body Radiation Therapy (SBRT), a standard approach for re-irradiation in this population.

Sponsor: IBA Proton Therapy, Inc.

Who Can Participate

Inclusion Criteria

Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits
Patients ≥ 18 years old
Patients ineligible for or decline upfront surgical resection
Histologically confirmed diagnosis of carcinoma of the head and neck
Prior receipt of at least 45 GyRBE radiotherapy to the head and neck
Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2 or evidence of similar in the electronic medical record
Life expectancy of more than 12 weeks
Ability to understand and the willingness to provide written informed consent and to follow the study procedures

Exclusion Criteria

Receipt of prior head and neck radiotherapy within the prior 6 months
Surgical resection of the current disease in the head and neck
More than 3 areas of disease requiring reirradiation
Disease focus exceeding 6.5 cm in greatest dimension
Presence of distant metastatic disease
Involvement of any of the following structures: skin, carotid artery, or mandible
Receipt of concurrent chemotherapy during radiotherapy
Uncontrolled intercurrent illness including medical and psychiatric, and social situations that would limit compliance with study requirements
Enrolled in any other investigational studies that involve administrations of another cancer therapeutic (such as surgery, chemotherapy, immunotherapy) during RT
Pregnant and/or breastfeeding

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Philadelphia?

Yes, this clinical trial (NCT07644585) has an active research site in Philadelphia, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Head and Neck Cancer Treatment Options in Philadelphia, PA

If you're searching for head and neck cancer treatment options in Philadelphia, PA, this clinical trial (NCT07644585) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all head and neck cancer clinical trials near you to find additional studies recruiting in your area.

More Head and Neck Cancer Trials in Philadelphia, PA

See all head and neck cancer clinical trials recruiting in Philadelphia — not just this study.

Browse Head and Neck Cancer Trials in Philadelphia →

Browse More Trials by Condition

Head and Neck Cancer TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Philadelphia?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Philadelphia, PA